Upregulation of LIGHT is seen in the liver of patients with NASH, but not in patients with ASH or chronic HCV infection, and may represent an NAFLD-specific way of disease progression [185]. The gene discussed is TNFSF14; the disease is metabolic dysfunction-associated steatohepatitis.